Skip to content

Clinical trials

Completed Phase 2 Carcinoma, Medullary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Medullary Phase: Phase 2 Status: Completed Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20053
20064
20071
20081
20101
20121
20131
20142
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
Amgen1
Bayer1
Columbia University1
Delcath Systems Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
Federico II University1
Genzyme, a Sanofi Company1
Kenneth Ain1
Massachusetts General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Medullary21
Thyroid Neoplasms15
Adenocarcinoma, Follicular10
Thyroid Cancer, Papillary10
Thyroid Carcinoma, Anaplastic6
Head and Neck Neoplasms5
Carcinoma, Hepatocellular3
Pancreatic Neoplasms3
Pheochromocytoma3
Colonic Neoplasms2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.